Flucoric 1 capsule 150 mg FLUCONAZOLUM Флюкорик

Flucoric INDICATIONS

1. Genital candidiasis, including vaginal candidiasis, acute or recurrent, candida balanitis. It is necessary to treat both partners.
Mucosal candidiasis, including oropharyngeal and oesophageal candidiasis, non-invasive bronchopulmonary infections, candiduria, mucocutaneous and chronic oral atrophic candidiasis, candidiasis skin.

2. skin mycoses, including athlete's foot, body, perineum and skin candidiasis.

3. Generalized candidiasis including candidemia, disseminated candidiasis and other forms of invasive Candida infections, which may include peritoneal infection, endocarditis, and infections of the respiratory and urinary systems.

4. Candida infections in patients with malignancy, in intensive care units (can be treated patients receiving cytotoxic or immunosuppressive therapy).

5. Cryptococcosis, including cryptococcal meningitis and infections of other sites (lung, skin); the drug can be administered to patients with AIDS, organ transplant immunosuppression or other factors; Flucoric capsules can be used as maintenance therapy for the prevention of relapse of cryptococcal infection in AIDS patients.

6. To prevent fungal infections in patients immunocompromised, in whom the risk of infection is increased as a result of neutropenia after cytotoxic chemotherapy or radiation therapy, including patients after bone marrow transplantation.

Samples for microbiological or other laboratory tests should be selected before the treatment to increase the reliability of the isolation and identification of pathogens.

Treatment can be started until culture results and other laboratory tests; However, after receiving the results of anti-infective therapy should be adjusted accordingly.

APPLICATION

Flucoric daily dose depends on the location and severity of fungal infection. For treatment of vaginal candidosis in most cases, a single dose.

Treatment of those types of infections requiring multiple injections of the drug, should continue until such time as the clinical parameters of lab tests will not confirm that the active fungal infection is cured. Insufficient duration of treatment may lead to recurrence of active infection. Patients with AIDS and cryptococcal meningitis usually require maintenance therapy to prevent relapse

CONTADICTIONS

- Hypersensitivity to fluconazole, other azole compounds or to any of the excipients of the drug.

- Concomitant use of fluconazole and terfenadine patients who use multiple fluconazole doses of 400 mg / day and above (according to a study of interaction between multiple application).

- Concomitant use of fluconazole and other drugs that prolong QT interval and are metabolized by the enzyme CYP2A4 (eg cisapride, astemizole, pimozide, quinidine and erythromycin).